ArticleJournal of translational medicine2025
Myomedin variants developed for in vitro PD-L1 diagnostics in tissue samples of non-small cell lung carcinoma patients.
Hana Petroková et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.